Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
0.5353
-0.0242 (-4.33%)
At close: Nov 12, 2026, 4:00 PM EST
0.5113
-0.0240 (-4.48%)
After-hours: Nov 12, 2026, 7:53 PM EST

Health In Tech Earnings Call Transcripts

Fiscal Year 2026

  • Q3 revenue and profitability declined amid carrier-transition timing, lower ICE fees, and a one-time credit provision, while SMR fees held steady and cash use improved sequentially. The focus is converting pipeline and launching new products, with 2027 guidance still under review.

  • AGM 2026

    All five director nominees were elected, and stockholders approved the authorized-share increase, SEPA issuance, amended 2024 Plan, and auditor ratification. Shares representing 90.53% of outstanding voting power were represented.

  • Q2 revenue declined due to timing shifts from new carrier onboarding, but contracted and pipeline revenue remain strong, supporting reaffirmed 2026 guidance of $45–$50 million. Platform upgrades, new product launches, and anticipated A-rated carrier partnerships are expected to drive future growth.

  • Q1 2026 revenue grew 9% to $8.8M, with a net loss of $1.6M as investments in sales, tech, and distribution accelerated. Full-year revenue guidance of $45–$50M was reiterated, and new platform features and products are driving positive broker feedback and future growth.

Fiscal Year 2025

Fiscal Year 2024